Taking sides in colon cancer

Clinicians treating patients with metastatic colorectal cancer may soon need to take sides – treating tumours on the left and right colon differently.

A post-hoc analysis of a clinical trial comparing two drugs additional to standard chemotherapy showed that overall survival of patients with left-sided primary tumours was 13.9 months longer than those with primaries on the right.